Skip to content

DR. I. BUNTINX

Active Private limited companyfounded 2011active for 15 yearsAzaleastraat 4, 8434 MiddelkerkeKBO/BCE: BE 0840.046.130

Lifetime

14 annual accounts with figures on one time axis
peak of €71,834 in 2018
€9,787▼ 84.2%
lowest -€44,520 in 2022
€1,351▼ 97.5%
peak of €101,056 in 2020
€35,057▲ 4.0%
€9,837▼ 6.8%
peak of 0.3 FTE in 2016
-not published
Board1 name since 2011
1 director
Owners
  
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €62,051 to €9,787Result from €53,200 to €1,3511 establishment registered

Key points

from the 2025 annual accounts

Equity

€35,057 from €101,056 in 2020

Equity fell by 65% in 5 years.

Result

€1,351 ▼ 97.5%
€53,2002024€1,3502025

The result fell in 2025 from €53,200 to €1,351.

Position in the sector

€1,351

Lower net result than 90% of companies in human health. Sector median €59,520 · 21,355 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,916 companies had the same profile as DR. I. BUNTINX has now. Each dot stands for 28 companies, two years later.

95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,916 companies, not a prediction for DR. I. BUNTINX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100%annual accounts 2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0840046130
New establishment in Aartselaar Kapellestraat 48
changes role from director, formerly manager to director “De uitoefening van de algemene geneeskunde, meer bepaald de uitoefening van een huisartspraktijk, door haar…” (deed in Dutch) · Director discharge: · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 04-12-2023 · Gazette deed
Registered-office move Director in office: · Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
DR. I. BUNTINX Middelkerke €44,894 €9,787 78.1% -
GOURMET SEBASTIEN Woluwe-Saint-Lambert €49,432 €10,730 99.5% -
DR. LOTHAIRE LECLERCQ Bruges €43,771 €8,572 51.8% -
DR. S. UYTDENHOUWEN Ghent €48,628 €10,092 91.8% -
Ad-Doc Consult Schaerbeek €40,524 €7,788 -56.9% -
CABINET MEDICAL G. GREGGIO Fontaine-l'Evêque €43,581 €8,825 91.5% -
CAMNO Nivelles €60,285 €8,280 96.5% -

These companies have the same main activity as DR. I. BUNTINX: general medical practice (NACE 86210). They are comparable in size and age: total assets between €40,500 and €60,300, founded between 2004 and 2017.

Official details

Source: KBO
Status
Active since 26-09-2011Normal situation
Activity
General medical practiceNACE 86210
Establishment units
2.203.216.5278434 Middelkerke, registered on 07-10-2011
2.376.540.0852630 Aartselaar, since 01-07-2025
Financial year end
31 December
Peppol
Reachable since 29-04-2026
Company details

Annual accounts 2025

≈ €60,000estimated
€44,894▲ 1.4%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on DR. I. BUNTINX

DR. I. BUNTINX files the micro format. That format states no turnover. The gross margin fell from €26,261 in 2012 to €9,787 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. I. BUNTINX

What is the company number of DR. I. BUNTINX?
The company number of DR. I. BUNTINX is 0840.046.130. The VAT number is the same number with BE in front: BE 0840.046.130.
Where is DR. I. BUNTINX based?
The registered office is at Azaleastraat 4, 8434 Middelkerke.Company details
What does DR. I. BUNTINX do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. I. BUNTINX?
DR. I. BUNTINX is a private limited company (BV).
When was DR. I. BUNTINX founded?
DR. I. BUNTINX was founded on 26-09-2011.
Is DR. I. BUNTINX still active?
Yes, DR. I. BUNTINX is an active enterprise in the KBO register.
What is the turnover of DR. I. BUNTINX?
The turnover in financial year 2025 is ≈ €60,000. This figure is estimated from the gross margin of €9,787 and 52 comparable companies (NACE 86). It probably lies between €42,000 and €110,000. It is a rough estimate.Financials
Is DR. I. BUNTINX profitable?
In financial year 2025, DR. I. BUNTINX made a profit of €1,351.
Where can I find the annual accounts of DR. I. BUNTINX?
DR. I. BUNTINX filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. I. BUNTINX due?
DR. I. BUNTINX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.